Castle Rock Wealth Management LLC Has $334,000 Position in UnitedHealth Group Incorporated $UNH

Castle Rock Wealth Management LLC lifted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 63.2% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,072 shares of the healthcare conglomerate’s stock after acquiring an additional 415 shares during the period. Castle Rock Wealth Management LLC’s holdings in UnitedHealth Group were worth $334,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of the stock. Bayforest Capital Ltd increased its stake in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd increased its stake in UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. IAG Wealth Partners LLC bought a new stake in UnitedHealth Group during the 1st quarter valued at $42,000. Kentucky Trust Co increased its stake in UnitedHealth Group by 53.8% during the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after purchasing an additional 50 shares in the last quarter. Finally, O Brien Wealth Partners LLC increased its stake in UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock valued at $46,000 after purchasing an additional 37 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on UNH. Piper Sandler reduced their target price on shares of UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Oppenheimer cut their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the stock an “overweight” rating in a report on Friday, September 12th. Barclays boosted their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an “overweight” rating in a report on Thursday, September 4th. Finally, Bank of America boosted their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a report on Wednesday. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and four have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $372.68.

UnitedHealth Group Price Performance

NYSE UNH opened at $369.88 on Thursday. The company has a market cap of $334.99 billion, a PE ratio of 16.03, a price-to-earnings-growth ratio of 2.35 and a beta of 0.47. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm’s 50-day simple moving average is $313.51 and its two-hundred day simple moving average is $352.54.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same period in the previous year, the company posted $6.80 earnings per share. The company’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.